Sirius Speciality Extracts Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.70 M
as on 04-12-2024
- Revenue 82.88%
(FY 2020)
- Profit -124.30%
(FY 2020)
- Ebitda 145.50%
(FY 2020)
- Net Worth -0.92%
(FY 2020)
- Total Assets 87.36%
(FY 2020)
About Sirius Speciality Extracts
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Radha Mathan and Premkumar Sriraman serve as directors at the Company.
- CIN/LLPIN
U74900TZ2014PTC020428
- Company No.
020428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sirius Speciality Extracts Private Limited offer?
Sirius Speciality Extracts Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Honey & Sweeteners, Natural Honey, Eucalyptus Honey.
Who are the key members and board of directors at Sirius Speciality Extracts?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radha Mathan  | Director | 01-Apr-2014 | Current |
| Premkumar Sriraman | Director | 05-May-2022 | Current |
Financial Performance of Sirius Speciality Extracts.
Sirius Speciality Extracts Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 82.88% increase. The company also saw a substantial fall in profitability, with a 124.3% decrease in profit. The company's net worth dipped by a decrease of 0.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirius Speciality Extracts?
In 2019, Sirius Speciality Extracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wild Blossom Honey India Private LimitedActive 5 years 4 monthsRadha Mathan and Premkumar Sriraman are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 May 2018 | ₹0.70 M | Open |
How Many Employees Work at Sirius Speciality Extracts?
Unlock and access historical data on people associated with Sirius Speciality Extracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirius Speciality Extracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirius Speciality Extracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
